FDA Finalizes Public Availability of Advisory Committee Members’ Financial Interest Information and Waivers — Participation Contingent on Public Disclosure Read more
GlaxoSmithKline Plans to Bring Physician Reps In-House Instead of Paying External Promotional Speakers Read more
CME Coalition Questions Pew Taskforce on COI Recommendations as “Irresponsible” and Potentially Dangerous to America’s Health Read more
Partners for Healthy Dialogues: Offers Prescription for Healthy Physician-Industry Interactions Read more